A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer¿s Disease o
Clinical Trial Grant
Administered By
Neurology, Behavioral Neurology
Awarded By
Biogen MA, Inc.
Start Date
January 27, 2023
End Date
December 31, 2027
Administered By
Neurology, Behavioral Neurology
Awarded By
Biogen MA, Inc.
Start Date
January 27, 2023
End Date
December 31, 2027